- Home
- XGN
XGN
Exagen Inc.
as 04-18-2025 1:45pm EST
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | VISTA |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $7.50 | AVG Volume (30 days): | 118.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.32 - $6.22 | Next Earning Date: | 05-12-2025 |
| Revenue: | $55,641,000 | Revenue Growth: | 5.89% |
| Revenue Growth (this year): | 17.4% | Revenue Growth (next year): | 15.04% |
Stock Insider Trading Activity of Exagen Inc. (XGN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | XGN | 10% Owner | Mar 25 '25 | Sell | $3.30 | 350,000 | $1,155,000.00 | 1,758,958 |
Latest Exagen Inc. News
XGN Breaking Stock News: Dive into XGN Ticker-Specific Updates for Smart Investing
Simply Wall St.
23 days ago
SurgePays And 2 Other Promising Penny Stocks To Watch
Simply Wall St.
a month ago
Exagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Simply Wall St.
a month ago
Exagen Full Year 2024 Earnings: EPS Beats Expectations
GuruFocus.com
a month ago
Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives
Thomson Reuters StreetEvents
a month ago
Q4 2024 Exagen Inc Earnings Call
Zacks
a month ago
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
GlobeNewswire
a month ago
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
Simply Wall St.
2 months ago
Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years
Compare XGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XGN Exagen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.